The National HIV Nurses Association (NHIVNA) is the leading UK professional association representing nurses in HIV care. Founded in 1998, it is a well-established and highly respected organisation committed to providing excellence in the care of those living with and affected by HIV.
The Association aims to provide an academic and educational forum for the dissemination of original nursing research in the field of HIV/AIDS. In addition, NHIVNA aims to address the communication and support needs of these nurses to assist in the promotion of best practice in the care of people with HIV. The Charity's objects are to advance education amongst members of the nursing profession about good nursing practices and to promote improved standards of nursing care of patients with HIV. In addition, NHIVNA supports research into the promotion of HIV nursing skills and aims to publish the results of such research for the benefit of the public.
The current membership of the Association is almost 350, located across the UK and Ireland. Membership benefits include subscription to the key journal HIV Nursing, the NHIVNA newsletter and free attendance at NHIVNA Study Days. For more details on the benefits of membership and how to join, please go to the Membership page.
Seeking members' views
NHIVNA values its members and seeks to empower them by three means: Research, Education and Support. The Association would be very grateful for members' views on how existing activities can be developed and enhanced. Please send your comments or suggestions to the Secretariat on firstname.lastname@example.org.
HPV16 highly prevalent among HIV-positive MSM in France and strongly associated with high-grade pre-cancerous anal lesions
Michael Carter | 1 day ago
HIV-positive gay men in France have a very high prevalence of anal infection with strains of h......MORE
PrEP does not raise lipids or alter body fat, safety study finds
Keith Alcorn | 5 days ago
Using PrEP does not raise lipid levels or have any substantial effect on body fat, investigato......MORE
Zambia: HIV deaths on treatment underestimated
Keith Alcorn | 6 days ago
People with HIV in Zambia were at least ten times more likely to die in the first two years af......MORE
Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason
Michael Carter | 7 days ago
Darunavir/ritonavir is the most durable boosted protease inhibitor for antiretroviral (ART)-ex......MORE